Enlivex (ENLV) Change in Acquisitions & Divestments (2014 - 2025)
Enlivex (ENLV) posted quarterly Change in Acquisitions & Divestments of $10.9 million for Q4 2025, up 156.4% year-over-year from $4.2 million in Q4 2024, and up 9.93% quarter-over-quarter from $9.9 million in Q3 2025.
Enlivex (ENLV) Change in Acquisitions & Divestments (2014 - 2025) Analysis & Trends
Enlivex's Change in Acquisitions & Divestments history runs 9 years deep, the most recent figure standing at $10.9 million for Q4 2025.
- In Q4 2025, Change in Acquisitions & Divestments rose 156.4% year-over-year to $10.9 million; the TTM figure through Dec 2025 stood at $41.4 million (up 5.42% YoY), while the FY2025 annual figure was $41.4 million, up 5.42% from the prior year.
- Change in Acquisitions & Divestments for Q4 2025 stood at $10.9 million, up from $9.9 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $62.5 million in Q1 2022, with the low at -$52.5 million in Q3 2022.
- The 5-year median for Change in Acquisitions & Divestments is $9.9 million (2025), against an average of $10.1 million.
- The sharpest annual moves came in 2022 and 2024: Change in Acquisitions & Divestments sank 620.13% in 2022, then jumped 11745.1% in 2024.
- Enlivex's Change in Acquisitions & Divestments stood at $17.9 million in 2021, then soared by 192.95% to $52.5 million in 2022, then slumped by 102.72% to -$1.4 million in 2023, then jumped by 397.48% to $4.2 million in 2024, then surged by 156.4% to $10.9 million in 2025.
- Business Quant data shows ENLV's Change in Acquisitions & Divestments at $10.9 million in Q4 2025, $9.9 million in Q3 2025, and $8.2 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Enlivex | 4.51 Mn | -1.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.88 Mn |
| Dec 31, 2025 | 10.88 Mn |
| Sep 30, 2025 | 9.90 Mn |
| Sep 30, 2025 | 9.90 Mn |
| Jun 30, 2025 | 8.17 Mn |
| Jun 30, 2025 | 8.17 Mn |
| Mar 31, 2025 | 12.41 Mn |
| Mar 31, 2025 | 12.41 Mn |
| Dec 31, 2024 | 4.25 Mn |
| Dec 31, 2024 | 4.25 Mn |
| Sep 30, 2024 | 12.08 Mn |
| Sep 30, 2024 | 12.08 Mn |
| Jun 30, 2024 | 9.51 Mn |
| Jun 30, 2024 | 9.51 Mn |
| Mar 31, 2024 | 13.40 Mn |
| Mar 31, 2024 | 13.40 Mn |
| Dec 31, 2023 | -1.43 Mn |
| Dec 31, 2023 | -1.43 Mn |
| Sep 30, 2023 | 102,000.00 |
| Sep 30, 2023 | 102,000.00 |